IPM grows at 9.9 per cent in May 2013
Valued at Rs 6100 crores
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
IPA to organise 6th Symposium on Nasal and Pulmonary Drug Delivery in Mumbai
Event to be held on October 24 and 25, to have a theme on ‘Global Regulatory Trends’
Parenteral Drug Association inaugurates its Indian chapter
Event held in Mumbai was attended by over 70 delegates from parenteral manufacturing and allied industry
Value-added OTCs on the radar
Pharmaceutical players are striving to add value to their OTC products in order to catch the consumer's attention and stand out…
‘The import tax anomalies faced by MD manufacturers, are tariff barriers erected against…
Ajay Pitre, Managing Director, Sushrut-Adler group shares his thoughts on the challenges facing the Indian medical device industry…
DoP calls for comments on soft loan scheme for mid-sized pharma cos
With a corpus fund of Rs 500 crores, the Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) aims to coax them to…
Cipla expands collaboration with Meda in allergic rhinitis segment
Will build further on the existing collaboration by granting global commercialisation rights to Meda for Dymista
Quest Life Sciences to tap US market
To register 10-15 products in the US market, expand its formulation facility in Chennai
Zydus pioneers Indias first NCE, introduces Lipaglyn
Will launch it in the Indian market by the end of third quarter
Sun Pharma announces US FDA approval for generic depo-testosterone injection
Is indicated for replacement therapy in males for conditions associated with symptoms of deficiency or absence of endogenous…
Dr Reddys and Fujifilm call off JV for generic drugs in Japan
Fujifilm realigns its long-term growth strategy for the pharma business
M&A activity increases significantly in value terms with a focus on core therapy areas
Indian pharma sector witnesses no deals during May 2013
SCDM Asia Conference receives overwhelming response
Event held for the first time in India sees more than 150 participants from seven countries
Thinking Green
Known as the 'bulk drug capital' of India, Andhra Pradesh is home to many pharmaceutical units. These units generate large…
‘Ayurveda is well versed with the toxic effects of Aristolochia indica’
Indian herbal medicines garnered the spotlight some time back with Aristolochic acid content in them tied to increasing risk of…
Pharmexcil signs MoU with CCCMHPIE
To promote cooperation and trade between India and China for pharma and healthcare industries
Countries must fix critical access to medicines flaws in Trans-Pacific Trade Pact: MSF
Access to medicines issues finally back on negotiators’ agenda after being sidelined for more than a year
Piramal Enterprises receives IND approval from US FDA for its anti-diabetic molecule
Will enable to initiate a phase I clinical trial of P11187
Suven secures three product patents
Patents received for the treatment of disorders associated with neurodegenerative diseases
IPM registers growth of 9.3 per cent in April 2013, valued at Rs 6239 crores
From therapeutic perspective, 10 therapies have outgrown the IPM story